To further define key signalling responses of ovarian cancer cells to treatment with BT, we analyzed the expression and activation/phosphorylation of cellular markers involved in pro-apoptotic (p38) or pro-survival (pAkt, NF-kB) signalling. The gene discussed is NFKB1; the disease is ovarian cancer.